| P50 | author | Sheldon W. Tobe | Q58091532 |
| | Marcel Lebel | Q75131540 |
| P2093 | author name string | Finlay A McAlister | |
| | Janusz Kaczorowski | |
| | Norman R C Campbell | |
| | Canadian Hypertension Education Program | |
| | Richard Z Lewanczuk | |
| | Luc Poirier | |
| | Ross Feldman | |
| | Margaret Moy Kwong | |
| P2860 | cites work | The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors | Q21563399 |
| | Results of the Ontario survey on the prevalence and control of hypertension | Q24643898 |
| | The BpTRU automatic blood pressure monitor compared to 24 hour ambulatory blood pressure monitoring in the assessment of blood pressure in patients with hypertension | Q24815566 |
| | Choices, persistence and adherence to antihypertensive agents: evidence from RAMQ data | Q31152110 |
| | Telmisartan, ramipril, or both in patients at high risk for vascular events | Q33156143 |
| | Persistence with treatment for hypertension in actual practice | Q34030347 |
| | Telmisartan to prevent recurrent stroke and cardiovascular events | Q34596294 |
| | The 2009 Canadian Hypertension Education Program recommendations for the management of hypertension: Part 2--therapy | Q34607311 |
| | Automated measurement of blood pressure in routine clinical practice | Q36775246 |
| | Prehypertension and hypertension in a primary care practice. | Q36936509 |
| | Chronic disease prevention: health effects and financial costs of strategies to reduce salt intake and control tobacco use | Q37026089 |
| | Trends in antihypertensive drug prescriptions and physician visits in Canada between 1996 and 2006 | Q37098424 |
| | Compliance, safety, and effectiveness of fixed-dose combinations of antihypertensive agents: a meta-analysis | Q37660789 |
| | Effects of the angiotensin-receptor blocker telmisartan on cardiovascular events in high-risk patients intolerant to angiotensin-converting enzyme inhibitors: a randomised controlled trial | Q42542786 |
| | Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients | Q46217490 |
| | Renal outcomes with telmisartan, ramipril, or both, in people at high vascular risk (the ONTARGET study): a multicentre, randomised, double-blind, controlled trial. | Q46426098 |
| | Automated oscillometric blood pressure versus auscultatory blood pressure as a predictor of carotid intima-medial thickness in male firefighters | Q47842384 |
| | Automated assessment of blood pressure using BpTRU compared with assessments by a trained technician and a clinic nurse | Q47858344 |
| | Comparison between an automated and manual sphygmomanometer in a population survey | Q47960913 |
| | Large increases in hypertension diagnosis and treatment in Canada after a healthcare professional education program. | Q50789154 |
| | Automated blood pressure measurement in routine clinical practice. | Q51248315 |
| | Increases in Antihypertensive Prescriptions and Reductions in Cardiovascular Events in Canada | Q59139520 |
| | Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients | Q60630346 |
| | Persistence and discontinuation patterns of antihypertensive therapy among newly treated patients: a population-based study | Q81791299 |
| | Awareness and misconception of hypertension in Canada: results of a national survey | Q81820761 |
| | Another major role for dietary sodium reduction: improving blood pressure control in patients with resistant hypertension | Q84264453 |
| P433 | issue | 5 | |
| P921 | main subject | arterial hypertension | Q41861 |
| P304 | page(s) | 236-240 | |
| P577 | publication date | 2010-05-01 | |
| P1433 | published in | The Canadian Journal of Cardiology | Q3502278 |
| P1476 | title | 2010 Canadian Hypertension Education Program (CHEP) recommendations: the scientific summary - an update of the 2010 theme and the science behind new CHEP recommendations | |
| P478 | volume | 26 | |